-
2
-
-
0031879906
-
Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians
-
Shields P.G., Lerman C., Audrain J., et al. Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 7 (1998) 453-458
-
(1998)
Cancer Epidemiol Biomarkers Prev
, vol.7
, pp. 453-458
-
-
Shields, P.G.1
Lerman, C.2
Audrain, J.3
-
3
-
-
0032481666
-
Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients
-
Spitz M.R., Shi H., Yang F., et al. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 90 (1998) 358-363
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 358-363
-
-
Spitz, M.R.1
Shi, H.2
Yang, F.3
-
4
-
-
33644664300
-
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation
-
Ferone D., Arvigo M., Semino C., et al. Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation. Am J Physiol Endocrinol Metab 289 (2005) E1044-E1050
-
(2005)
Am J Physiol Endocrinol Metab
, vol.289
-
-
Ferone, D.1
Arvigo, M.2
Semino, C.3
-
5
-
-
33646576910
-
Dopamine regulation of Amiloride-sensitive sodium channels in lung cells
-
Helms M.N., Chen X.J., Ramosevac S., Eaton D.C., and Jain L. Dopamine regulation of Amiloride-sensitive sodium channels in lung cells. Am J Physiol Lung Cell Mol Physiol 290 (2005) L710-L722
-
(2005)
Am J Physiol Lung Cell Mol Physiol
, vol.290
-
-
Helms, M.N.1
Chen, X.J.2
Ramosevac, S.3
Eaton, D.C.4
Jain, L.5
-
6
-
-
0028362943
-
Inhibition of growth of human small cell lung cancer by bromocriptine
-
Ishibashi M., Fujisawa M., Furue H., Maeda Y., Fukayama M., and Yamaji T. Inhibition of growth of human small cell lung cancer by bromocriptine. Cancer Res 54 (1994) 3442-3446
-
(1994)
Cancer Res
, vol.54
, pp. 3442-3446
-
-
Ishibashi, M.1
Fujisawa, M.2
Furue, H.3
Maeda, Y.4
Fukayama, M.5
Yamaji, T.6
-
8
-
-
0242329749
-
D2s dopamine receptor mediates phospholipase D and antiproliferation
-
Senogles S.E. D2s dopamine receptor mediates phospholipase D and antiproliferation. Mol Cell Endocrinol 209 (2003) 61-69
-
(2003)
Mol Cell Endocrinol
, vol.209
, pp. 61-69
-
-
Senogles, S.E.1
-
9
-
-
0036717151
-
Reduced tumour growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system
-
Teunis M.A., Kavelaars A., Voest E., et al. Reduced tumour growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system. FASEB J 16 (2002) 1465-1467
-
(2002)
FASEB J
, vol.16
, pp. 1465-1467
-
-
Teunis, M.A.1
Kavelaars, A.2
Voest, E.3
-
10
-
-
0032965290
-
Decreased dopamine receptor expression and its second-messenger cAMP in malignant human colon tissue
-
Basu S., and Dasgupta P.S. Decreased dopamine receptor expression and its second-messenger cAMP in malignant human colon tissue. Dig Dis Sci 44 (1999) 916-921
-
(1999)
Dig Dis Sci
, vol.44
, pp. 916-921
-
-
Basu, S.1
Dasgupta, P.S.2
-
11
-
-
4143067127
-
Ablation of peripheral dopaminergic nerves stimulates malignant tumour growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis
-
Basu S., Sarkar C., Chakroborty D., et al. Ablation of peripheral dopaminergic nerves stimulates malignant tumour growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis. Cancer Res 64 (2004) 5551-5555
-
(2004)
Cancer Res
, vol.64
, pp. 5551-5555
-
-
Basu, S.1
Sarkar, C.2
Chakroborty, D.3
-
12
-
-
33644870366
-
Polymorphisms of DNA repair genes and risk of non-small cell lung cancer
-
Zienolddiny S., Campa D., Lind H., et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27 (2006) 560-567
-
(2006)
Carcinogenesis
, vol.27
, pp. 560-567
-
-
Zienolddiny, S.1
Campa, D.2
Lind, H.3
-
13
-
-
0242691208
-
A comparison of bayesian methods for haplotype reconstruction from population genotype data
-
Stephens M., and Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73 (2003) 1162-1169
-
(2003)
Am J Hum Genet
, vol.73
, pp. 1162-1169
-
-
Stephens, M.1
Donnelly, P.2
-
14
-
-
0030933979
-
A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia
-
Arinami T., Gao M., Hamaguchi H., and Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 6 (1997) 577-582
-
(1997)
Hum Mol Genet
, vol.6
, pp. 577-582
-
-
Arinami, T.1
Gao, M.2
Hamaguchi, H.3
Toru, M.4
-
15
-
-
23044434010
-
The dopamine D2 receptor: new surprises from an old friend
-
Bonci A., and Hopf F.W. The dopamine D2 receptor: new surprises from an old friend. Neuron 47 (2005) 335-338
-
(2005)
Neuron
, vol.47
, pp. 335-338
-
-
Bonci, A.1
Hopf, F.W.2
-
16
-
-
22244478946
-
Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk
-
Gemignani F., Landi S., Moreno V., et al. Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 14 (2005) 1633-1638
-
(2005)
Cancer Epidemiol Biomarkers Prev
, vol.14
, pp. 1633-1638
-
-
Gemignani, F.1
Landi, S.2
Moreno, V.3
-
17
-
-
8544279584
-
Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism
-
Finckh U., Rommelspacher H., Kuhn S., et al. Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism. Pharmacogenetics 7 (1997) 271-281
-
(1997)
Pharmacogenetics
, vol.7
, pp. 271-281
-
-
Finckh, U.1
Rommelspacher, H.2
Kuhn, S.3
-
18
-
-
0033626548
-
D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study
-
Wu X., Hudmon K.S., Detry M.A., Chamberlain R.M., and Spitz M.R. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev 9 (2000) 1021-1026
-
(2000)
Cancer Epidemiol Biomarkers Prev
, vol.9
, pp. 1021-1026
-
-
Wu, X.1
Hudmon, K.S.2
Detry, M.A.3
Chamberlain, R.M.4
Spitz, M.R.5
-
19
-
-
0031752522
-
The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers
-
Pohjalainen T., Rinne J.O., Nagren K., et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3 (1998) 256-260
-
(1998)
Mol Psychiatry
, vol.3
, pp. 256-260
-
-
Pohjalainen, T.1
Rinne, J.O.2
Nagren, K.3
-
20
-
-
0033542110
-
A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia
-
Okuyama Y., Ishiguro H., Toru M., and Arinami T. A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. Biochem Biophys Res Commun 258 (1999) 292-295
-
(1999)
Biochem Biophys Res Commun
, vol.258
, pp. 292-295
-
-
Okuyama, Y.1
Ishiguro, H.2
Toru, M.3
Arinami, T.4
-
21
-
-
23444458557
-
Dopamine transporter (SLC6A3) 5′ region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease
-
Kelada S.N., Costa-Mallen P., Checkoway H., et al. Dopamine transporter (SLC6A3) 5′ region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease. Pharmacogenet Genomics 15 (2005) 659-668
-
(2005)
Pharmacogenet Genomics
, vol.15
, pp. 659-668
-
-
Kelada, S.N.1
Costa-Mallen, P.2
Checkoway, H.3
-
22
-
-
3042734848
-
Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis
-
Chakroborty D., Sarkar C., Mitra R.B., Banerjee S., Dasgupta P.S., and Basu S. Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis. Clin Cancer Res 10 (2004) 4349-4356
-
(2004)
Clin Cancer Res
, vol.10
, pp. 4349-4356
-
-
Chakroborty, D.1
Sarkar, C.2
Mitra, R.B.3
Banerjee, S.4
Dasgupta, P.S.5
Basu, S.6
-
23
-
-
14744294101
-
Dopamine inhibits cell growth and cell cycle by blocking ribonucleotide reductase
-
Woldman I., Reither H., Kattinger A., Hornykiewicz O., and Pifl C. Dopamine inhibits cell growth and cell cycle by blocking ribonucleotide reductase. Neuropharmacology 48 (2005) 525-537
-
(2005)
Neuropharmacology
, vol.48
, pp. 525-537
-
-
Woldman, I.1
Reither, H.2
Kattinger, A.3
Hornykiewicz, O.4
Pifl, C.5
-
24
-
-
0041430890
-
Anti-proliferative effects and cell death mediated by two isoforms of dopamine D2 receptors in pituitary tumour cells
-
An J.J., Cho S.R., Jeong D.W., Park K.W., Ahn Y.S., and Baik J.H. Anti-proliferative effects and cell death mediated by two isoforms of dopamine D2 receptors in pituitary tumour cells. Mol Cell Endocrinol 206 (2003) 49-62
-
(2003)
Mol Cell Endocrinol
, vol.206
, pp. 49-62
-
-
An, J.J.1
Cho, S.R.2
Jeong, D.W.3
Park, K.W.4
Ahn, Y.S.5
Baik, J.H.6
-
25
-
-
0035725833
-
Dopamine induces phenotypic differentiation or apoptosis in a dose-dependent fashion: involvement of the dopamine transporter and p53
-
Porat S., Premkumar A., and Simantov R. Dopamine induces phenotypic differentiation or apoptosis in a dose-dependent fashion: involvement of the dopamine transporter and p53. Dev Neurosci 23 (2001) 432-440
-
(2001)
Dev Neurosci
, vol.23
, pp. 432-440
-
-
Porat, S.1
Premkumar, A.2
Simantov, R.3
-
26
-
-
0035026748
-
The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor
-
Basu S., Nagy J.A., Pal S., et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 7 (2001) 569-574
-
(2001)
Nat Med
, vol.7
, pp. 569-574
-
-
Basu, S.1
Nagy, J.A.2
Pal, S.3
|